Drug Target Review2024-01-11T16:00:52
Disruptions in TP53 and RB1 are key influencers that cause changes in the risk of mutations across chromosomes.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-22T07:00:00Z
Contributor Luca Lotta, Drug Target Review
2026-09-18T15:56:00Z
Contributor Dr Garegin Papoian, Drug Target Review
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
2026-07-23T06:20:00
Contributor Laura Lotfi, Drug Target Review
2026-09-10T08:41:00
Sponsored by DNA Genotek Inc.
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2023-07-04T10:05:58
Sponsored by Revvity
2026-07-08T07:58:00
Contributor Dr Nick Lynch, Dr Raminderpal Singh
Site powered by Webvision Cloud